Membership Home Portfolio Stocks Bonds Funds ETFs CEFs Markets Tools Real Life Finance Discuss
Home>Topics>>IPO Preview: Cancer Genetics

IPO Preview: Cancer Genetics

IPO Analysis from Seeking Alpha

Tue, 12 Feb 2013

By IPOdesktop : Based in Rutherford, NJ, Cancer Genetics ( CGIX ) scheduled a $35 million IPO with a market capitalization of $80 million at a price range mid-point of $7, for Wednesday, February 13, 2013. Five IPOs are scheduled for the week of February 11. The full IPO calendar is available here ...

Read the rest of this article on IPO Analysis from Seeking Alpha

Related Topics:

  1. IPO
  2. IPOs

Related Videos

  1. First Day Pop Doesn't Spell Long-Term Success for IPOs

    Tue, 15 May 2012

    Recent tech IPOs have had great first days, but performance has lagged since then, says Morningstar's James Krapfel.

Content Partners
Site Directory Site Map Our Products
Corrections Help Advertising Opportunities Licensing Opportunities Glossary RSS Mobile Portfolio Affiliate Careers Company News
International Sites: Australia Canada China France Germany Hong Kong Italy The Netherlands Norway Spain U.K. Switzerland India Finland
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.

© Copyright 2013 Morningstar, Inc. All rights reserved. Please read our Terms of Useand Privacy Policy.Dow Jones Industrial Average, S&P 500, Nasdaq, and Morningstar Index (Market Barometer) quotes are real-time.